Posted on Leave a comment

Safe-T Group Ltd. Stock Trades Bullish In 2023; Subsidiary Expansion And Record Earnings Power The Move ($SFET)

Safe-T Group Ltd. (NASDAQ, TASE: SFET) stock is starting 2023 in a bullish mood. Since the start of the year, SFET shares are higher by over 10% to $2.70 at press-time on Wednesday. And the better news from an investor’s perspective is that the momentum into the new year is fueled by updates showing that […]

Posted on Leave a comment

Clearmind Medicine Inc.’s Psychedelic-Based Therapeutics Are Revolutionary To The Pharmaceutical Sector; Treating AUD In The Crosshairs ($CMND)

Weakness in Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) stock is less a trend than it is an opportunity. In fact, the decline in value over the past two weeks may be well overdone, noting that a series of milestones reached, patents earned, and valuable partnerships ideally position CMND to have its best year in […]

Posted on Leave a comment

Safe-T Group Ltd. Gets Bigger By Expanding Revenue-Generating Reach Of Wholly Owned NetNut Subsidiary ($SFET)

Safe-T Group Ltd. (NASDAQ, TASE: SFET) keeps getting bigger. Last week, the company announced that its wholly owned subsidiary and enterprise privacy network unit, NetNut, is expanding its presence into the price comparison market, intending to accelerate growth through travel sector customer acquisitions involving price comparison websites (PCW). According to DataINTELO, the global price comparison […]

Posted on Leave a comment

Paula Cherie, named CEO and Spiritual and Business Coach at Virtual Women’s Breakthrough and Power Breakthrough

Paula Cherie, entrepreneur, and portrait studio owner has been named the CEO and spiritual and business coach at Virtual Women’s Expo and Power Breakthrough Summit. With 12 years of experience as an entrepreneur and a passion for helping others reach their full potential, Paula Cherie is excited to take on this new role. As a […]

Posted on Leave a comment

Clearmind Medicine Inc. Positions To Deliver A First-To-Market Psychedelic-Based Treatment For AUD ($CMND)

Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) is blazing a trail in an emerging sector of pharmaceuticals: psychedelics. Thanks to a series of milestones reached, patents earned, and valuable partnerships, the company’s lead candidate, MEAI, may soon become the first-to-market psychedelic-based treatment targeting Alcohol Use Disorder (AUD). As an alcohol-substitute product, MEAI positions Clearmind to […]

Posted on Leave a comment

AppTech Payments Corp Shares Consolidate After Q4 Surge; Imminent Commerse™ Platform Launch Keeps Stock In Play ($APCX)

AppTech Payments Corp. (NASDAQ: APCX) stock saw some profit-taking. But based on the past two days of trading, the bullish momentum is still a force to reckon with. Last Thursday, APCX stock soared about 18% despite a considerable selloff in the broader markets. On Friday, APCX shares held gains, trading within a tight range and […]

Posted on Leave a comment

AppTech Payments Corp Stock Bullish Ahead Of Commerse™ Platform Launch ($APCX)

AppTech Payments Corp. (NASDAQ: APCX) stock may be consolidating, but the Q4 rally from a technical basis remains intact. On Monday, APCX shares touched $1.10, a 61% increase from its initial standing in Q4 and an impressive 81% over the start of Q2. While shares may have pulled back yesterday, volume remains higher than average […]

Posted on Leave a comment

KWIK’s Integration With Shopify Exposes A Valuation Disconnect Too Significant To Ignore ($KWIK)

KwikClick Inc. (OTCQB: KWIK) announced yesterday morning that it’s in the final stages of integrating its technology into the world’s largest E-commerce platform- Shopify. With that being the case, and with KWIK noting that the Shopify (NASDAQ: SHOP) deal will likely be followed with ones from Woo Commerce and Magento, it’s surprising that KWIK stock […]

Posted on Leave a comment

Avalon GloboCare Shares Higher; Partnerships And Planned Acquisition Fuel Investor Interest ($ALBT)

Thinly traded Avalon GloboCare (NASDAQ: ALBT) stock is worthy of consideration, and savvy investors appear to be doing just that. In fact, shares moved more than 5% higher last week, touching $0.38 on higher-than-normal volume. By the way, calling ALBT shares “thinly traded” doesn’t imply that they are entirely under the radar. They certainly aren’t, […]

Posted on Leave a comment

Actinium Pharmaceuticals’ Shares Stay Bullish Ahead Of Expected Topline Phase 3 Data Release In Q4 ($ATNM)

The bullish sentiment pushing Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) shares higher isn’t slowing. The stock held close to its monthly highs despite bearish market conditions weighing heavy on smallcap biotechs. Since the start of Q4, ATNM shares are higher by over 52% at press time, reaching $11.30 on Friday on higher than average volume. Perhaps […]